期刊文献+

尘螨过敏性支气管哮喘患者肺泡巨噬细胞表面CD_(86)的表达及抗CD_(86)单抗对其炎性细胞因子生成的作用 被引量:2

CD_(86) expression on alveolar macrophages and effects of anti-CD_(86) monoclonal antibody on the production of inflammatory cytokines in dust-mite allergic asthma patients
原文传递
导出
摘要 目的 观察尘螨过敏性支气管哮喘 (简称哮喘 )患者肺泡巨噬细胞表面CD86的表达 ,探讨抗CD86单抗抑制哮喘炎症反应的机制。方法 从 10例尘螨过敏性哮喘患者支气管肺泡灌洗液(BALF)和外周血中分离出肺泡巨噬细胞 (AM)和CD+ 4 T淋巴细胞 ,AM经螨变应原的刺激活化后与CD+ 4 T淋巴细胞共培养。每例患者的培养细胞分为抗CD86单抗干预组和CD86表达组 ,每组内再分为实验组和对照组。抗CD86单抗干预组、实验组分别加抗CD86单抗至 0 1mg/L(低剂量 )和 1.0mg/L(高剂量 )两个剂量 ,对照组不加相应抗体。共培养 72h后分别留取培养上清液 ,用酶联免疫吸附测定(ELISA)法检测细胞因子γ干扰素 (INF γ)、白细胞介素 4 (IL 4 )、IL 5的产生量。CD86表达组、实验组加螨变应原 ,对照组不加变应原 ,共培养 2 4h后收集培养细胞 ,流式细胞仪 (FCM)检测AM表面CD86分子的表达水平。结果 AM在尘螨变应原的刺激活化下 ,实验组AM表面CD86分子平均荧光密度表达水平为 (5 0± 9) % ,对照组为 (2 3± 5 ) % ,两组比较差异有显著性 (P <0 0 1) ;实验低剂量组IL 4、IL 5的分泌量分别为 (135± 19)ng/L、(10 4± 2 1)ng/L ,实验高剂量组分别为 (90± 17)ng/L、(6 8± 14 )ng/L ,对照组IL 4、IL 5的分泌量分别为 (187± 2 4 )ng/L。 Objective To investigate the CD_ 86 molecule expression on alveolar macrophages(AMs) before and after AM activation with dust-mite allergen and effects of anti-CD_ 86 monoclonal antibody on the production of inflammatory cytokines produced by cultured CD +_4 T cells, and to explore the pathogenesis of anti-CD_ 86 monoclonal antibody on inhibiting asthmatic inflammation. Methods AMs and CD +_4 T cells were isolated from brochoalveolar lavage fluid (BALF) and from peripheral blood derived from 10 asthma patients allergic to house dust-mite dermatophagoides pteronyssinus. AMs were stimulated and activated by house dust-mite allergen and co-cultured with CD +_4 T cells. The co-cultured cells were divided into anti-CD_ 86 monoclonal antibody intervention group and CD_ 86 expression group with which the control groups were set up. The anti-CD_ 86 antibody was added to 0.1 mg/L and 1.0 mg/L in the experiment group and no antibody was added in the control group. The supernatants were harvested after 72 hour co-culture. The concentration of interferon-gamma(INF-γ), interleukin-4(IL-4) and IL-5 were determined by enzyme linked immunosorbent assay(ELISA). CD_ 86 expression group was divided into experiment and control groups,and house dust-mite allergen was added to the experiment group but no allergen was added in the control group. The cells of the two groups were harvested after 24 hour co-culture. The CD_ 86 molecule expression on the AMs was detected by flow cytometry. Results After activated by house dust-mite allergen,the average fluorescence density of CD_ 86 on AM in the experiment group [(50±9)%] was significantly higher than that in the control group [(23±5)%,P <0.01]. The production of IL-4 and IL-5 was (135±19)ng/L,and (104±21) ng/L in the low-dose group respectively;(90±17)ng/L and (68±14) ng/L in the high-dose group;(187±24)ng/L and (161±23)ng/L in the control group;the differences among groups were significant ( P <0.01). The production of IFN-γ was (193±39)ng/L in the low-dose group and (201±47)ng/L in the high-dose group respectively,and there was no significant difference between the two groups( P >0.05). Conclusion AMs may effectively present allergen to T cells in allergic asthma patients. Anti-CD_ 86 monoclonal antibody can inhibit the production of IL-4 and IL-5 by blocking the co-stimulatory signal of CD +_ 4 T cells. These data suggestes that anti-CD_ 86 monoclonal antibody may hold therapeutic potentials in asthma by inhibiting airway inflammation.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2004年第5期302-305,共4页 Chinese Journal of Tuberculosis and Respiratory Diseases
基金 全军"十五"卫生科研基金资助项目 (0 1MA0 0 1)
  • 相关文献

参考文献13

  • 1Mark DA, Donovan CE, De Sanctis GT, et al. Both CD80 and CD86 co-stimulatory molecules regulate allergic pulmonary inflammation. Int Immunol, 1998,10:1647-1655.
  • 2Mathur M, Herrmann K, Qin Y, et al. CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice. Am J Respir Cell Mol Biol, 1999,21:498-509.
  • 3Koike E, Kobayashi T, Nelson DJ, et al. Effect of ozone exposure on alveolar macrophage-mediated immunosuppressive activity in rats. Toxicol Sci,1998,41:217-223.
  • 4Burastero SE, Magnani Z, Confetti C, et al. Increased expression of the CD80 accessory molecule by alveolar macrophages in asthmatic subjects and its functional involvement in allergen presentation to autologous Th2 lymphocytes. J Allergy Clin Immunol, 19
  • 5Balbo P, Silvestri M, Rossi GA, et al. Differential role of CD80 and CD86 on alveolar macrophages in the presentation of allergen to T lymphocytes in asthma. Clin Exp Allergy, 2001,31:625-636.
  • 6Haczku A, Takeda K, Redai I, et al. Anti-CD86(B7.2) treatment abolishes allergic airway hyperresponsiveness in mice. Am J Respir Crit Med, 1999,159(5 pt 1):1638-1643.
  • 7Khan S, McClellan JS, Knutsen AP. Increased sensitivity to IL-4 in patients with allergic bronchopulmonary aspergillosis. In Arch Allergy Immunol, 2000,123:319-326.
  • 8Hakonarson H, Kim C, Whelan R, et al. Bi-directional activation between human airway smooth muscle cells and T lymphocytes: role in induction of altered airway responsiveness. J Immunol, 2001,166:293-303.
  • 9Larche M, Till SJ, Haselden BM, et al. Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics. J Immunol, 1998,161:6375-6382.
  • 10Hofer MF, Jirapongsananurruk O, Trumble AE, et al. Upregulation of B7.2, but not B7.1, on B cells from patients with allergic asthma. J Allergy Clin Immunol, 1998,101(1 pt 1): 96-102.

二级参考文献4

共引文献3788

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部